At meeting held on 21 November 2017
The Board of Span Divergent has approved making investment in Quest Biochemicals subject to prerequisite approvals / conditions as may be required.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
